Biocon Told to Submit Detailed Toxicity, SAE Data on Semaglutide Prefilled Pen After Animal Deaths Written By Susmita Roy21 Oct 2025 1:00 PM ISTNew Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has opined that Biocon...
CDSCO Panel Clears Eli Lilly's Tirzepatide for Phase IV Clinical Trial in India Written By Susmita Roy21 Oct 2025 12:30 PM ISTNew Delhi: The Subject Expert Committee (SEC), functioning under the Central Drugs Standard Control Organisation (CDSCO), has granted permission to...
Novo Nordisk inks pact with Omeros for clinical-stage MASP-3 inhibitor zaltenibart Written By Ruchika Sharma21 Oct 2025 12:30 PM ISTDenmark: Novo Nordisk and Omeros Corporation have announced that they have entered into a definitive asset purchase and license agreement for the...
Boehringer Ingelheim, AimedBio collaborate to develop ADC therapy for cancer Written By Ruchika Sharma21 Oct 2025 11:59 AM ISTBoehringer Ingelheim and AimedBio, a biotechnology company specializing in the development of antibody-based therapeutics, have announced a global...
CDSCO Panel Rejects Pure and Cure's Empagliflozin-Based FDC, Flags Risk of UTI, Genital Mycosis Written By Susmita Roy20 Oct 2025 5:44 PM ISTNew Delhi: Citing that there is a concern of the risk of genital mycosis and urinary tract infection (UTI) with Empagliflozin, the Subject Expert...
Dr. Reddy's Labs Gets CDSCO Panel Nod to Manufacture, Market Semaglutide Injection Written By Susmita Roy20 Oct 2025 5:35 PM ISTNew Delhi: In a major development for diabetes care in India, Dr. Reddy's Labs has got the go-ahead from the Subject Expert Committee (SEC) functional...
Boston Scientific to acquire Nalu Medical for USD 533 million Written By Ruchika Sharma20 Oct 2025 2:15 PM ISTMarlborough: Boston Scientific Corporation has announced it has entered into a definitive agreement to acquire Nalu Medical, Inc., a privately...
AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosus Written By Ruchika Sharma20 Oct 2025 1:00 PM ISTAstraZeneca has announced that Saphnelo (anifrolumab) has been recommended for approval in the European Union (EU) as a self-administered...
Viatris buys Aculys Pharma to expand neurology portfolio in Japan Written By Ruchika Sharma20 Oct 2025 12:45 PM ISTPittsburgh: Viatris Inc., a global healthcare company, has announced it has acquired Aculys Pharma, Inc., a clinical-stage...
Novartis Scemblix receives positive CHMP opinion for newly diagnosed CML in adults Written By Ruchika Sharma19 Oct 2025 4:15 PM ISTBasel: Novartis has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a...
Strides, Incepta partner to expand women health access with WHO prequalified contraceptive Written By Ruchika Sharma19 Oct 2025 2:15 PM ISTBangalore: Strides Pharma Science Limited has announced that one of its step-down wholly owned subsidiary will market the WHO-prequalified...
IPC Launches QR Code-Enabled Online ADR Reporting Platform to Boost Patient Safety Written By Susmita Roy19 Oct 2025 1:15 PM ISTNew Delhi: In a major push toward digital healthcare transparency and patient safety, the Indian Pharmacopoeia Commission (IPC) under the Ministry of...
